COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 191: Articles 1901-1910  | Next

A human commons cell atlas reveals cell type specificity for OAS1 isoforms
Galvez-Merchan, A., Booeshaghi, A. S., Pachter, L.
10.1101/2024.03.23.586412 — Posted: 2024-03-24
Greater Role of Cognitive Impairment Over Fatigue in Post-COVID-19 Quality of Life: A Post-Hoc Analysis of a Randomized Controlled Trial
Kwan, A. T. H., Lakhani, M., Le, G. H., Singh, G., Teopiz, K. M., Guo, Z., Ceban, F., Dhaliwal, K. K., Badulescu, S., Ho, R., Rhee, T. G., Cao, B., d'Andrea, G., McIntyre, R. S.
10.1101/2024.03.20.24304411 — Posted: 2024-03-22
Predictive validity of the simplified Radiographic Assessment of Lung Edema score for the mortality in critically ill COVID-19 patients with the B.1.617.2 (Delta) variant in Vietnam: a single-centre, cross-sectional study
Do, S. N., Dang, T. Q., Luong, C. Q., Nguyen, M. H., Pham, D. T., Nguyen, V. K., Do, T. D., Nguyen, T. Q., Nong, V. M., Vo, K. H., Nguyen, T. C., Khuat, N. H., Pham, Q. T., Hoang, D. T., Nguyen, A. D., Nguyen, P. M., Cao, D. D., Pham, D. T., Dang, D. T., Nguyen, D. T., Nguyen, V. D., Le, T. Q., Ngo, H. D., Nguyen, D. V., Pham, T. T., Nguyen, D. T., Nguyen, N. T., Huynh, N. T., Phan, N. T., Nguyen, C. D., Vu, T. T., Do, C. D., Nguyen, C. V., Vu, G. V., Dao, C. X.
10.1101/2024.03.20.24304599 — Posted: 2024-03-22
Improved diagnosis of COVID-19 vaccine-associated myocarditis with cardiac scarring identified by cardiac magnetic resonance imaging.
Warren, J., Cheng, D., Crawford, N., Jones, B., Alafaci, A., Stub, D., Lew, P., Taylor, A.
10.1101/2024.03.20.24304640 — Posted: 2024-03-22
Development of Prediction Models of COVID-19 Vaccine Uptake among Lebanese and Syrians in a district of Beirut, Lebanon: a population-based study
Ragi, M. E., Ghattas, H., Shamas, H., DeJong, J., Melhem, N. M., McCall, S. J., CAEP Study Group
10.1101/2024.03.21.24304659 — Posted: 2024-03-22
Neutralisation sensitivity of the SARS-CoV-2 BA.2.87.1 variant
Sheward, D. J., Marking, U., Bladh, O., Held, S., Looyens, E., Vandenabeele, L., Muschiol, S., Aguilera, K., Norin, N. G., Oling, S., Westerberg, M., Martin, D., Hedestam, G. B. K., Albert, J., Thalin, C., Murrell, B.
10.1101/2024.03.21.586176 — Posted: 2024-03-22
Design of Antigen-Specific Antibody CDRH3 Sequences Using AI and Germline-Based Templates
Marinov, T. M., Abu-Shmais, A., Janke, A. K., Georgiev, I.
10.1101/2024.03.22.586241 — Posted: 2024-03-22
Bivalent COVID-19 vaccines boost the capacity of pre-existing SARS-CoV-2-specific memory B cells to cross-recognize Omicron subvariants
Fryer, H. A., Geers, D., Gommers, L., Zaeck, L. M., Tan, N. H., Jones-Freeman, B., Goorhuis, A., Postma, D. F., Visser, L. G., Hogarth, P. M., Koopmans, M. P. G., GeurtsvanKessel, C. H., O'Hehir, R. E., van der Kuy, P. H. M., de Vries, R. D., van Zelm, M. C.
10.1101/2024.03.20.585861 — Posted: 2024-03-22
Development of radiofluorinated MLN-4760 derivatives for PET imaging of the SARS-CoV-2 entry receptor ACE2
Wang, J., Beyer, D., Vaccarin, C., He, Y., Tanriver, M., Benoit, R. M., Deupi, X., Mu, L., Bode, J. W., Schibli, r., Mueller, C.
10.1101/2024.03.20.585792 — Posted: 2024-03-21
SARS-CoV-2 infection activates inflammatory macrophages in vascular immune organoids
Chau, C. W., To, A., Au-Yeung, R. K. H., Tang, K., Xiang, Y., Ruan, D., Zhang, L., Wong, H., Zhang, S., Au, M. T., Chung, S., Song, E., Choi, D.-H., Liu, P., Yuan, S., Wen, C., Sugimura, R.
10.1101/2024.03.20.585837 — Posted: 2024-03-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).